九个中等收入国家的医疗保健战略采购经验:系统性定性审查

IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES International Journal of Health Policy and Management Pub Date : 2023-11-06 DOI:10.34172/ijhpm.2023.7352
J. Sumankuuro, Frances Griffiths, A. Koon, Witness Mapanga, Beryl Maritim, A. Mosam, J. Goudge
{"title":"九个中等收入国家的医疗保健战略采购经验:系统性定性审查","authors":"J. Sumankuuro, Frances Griffiths, A. Koon, Witness Mapanga, Beryl Maritim, A. Mosam, J. Goudge","doi":"10.34172/ijhpm.2023.7352","DOIUrl":null,"url":null,"abstract":"Background: Efforts to move towards universal health coverage (UHC) aim to rebalance health financing in ways that increase efficiency, equity, and quality. Resource constraints require a shift from passive to strategic purchasing (SP). In this paper, we report on the experiences of SP in public sector health insurance schemes in nine middle-income countries to understand what extent SP has been established, the challenges and facilitators, and how it is helping countries achieve their UHC goals. Methods: We conducted a systematic search to identify papers on SP. Nine countries were selected for case study analysis. We extracted data from 129 articles. We used a common framework to compare the purchasing arrangements and key features in the different schemes. The evidence was synthesised qualitatively. Results: Five countries had health technology assessment (HTA) units to research what services to buy. Most schemes had reimbursement mechanisms that enabled some degree of cost control. However, we found evidenced-based changes to the reimbursement mechanisms only in Thailand and China. All countries have some form of mechanism for accreditation of health facilities, although there was considerable variation in what is done. All countries had some strategy for monitoring claims, but they vary in complexity and the extent of implementation; three countries have implemented e-claim processing enabling a greater level of monitoring. Only four countries had independent governance structures to provide oversight. We found delayed reimbursement (six countries), failure to provide services in the benefits package (four countries), and high out-of-pocket (OOP) payments in all countries except Thailand and Indonesia, suggesting the schemes were failing their members. Conclusion: We recommend investment in purchaser and research capacity and a focus on strong governance, including regular engagement between the purchaser, provider and citizens, to build trusting relationships to leverage the potential of SP more fully, and expand financial protection and progress towards UHC.","PeriodicalId":14135,"journal":{"name":"International Journal of Health Policy and Management","volume":"39 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Experiences of Strategic Purchasing of Healthcare in Nine Middle-Income Countries: A Systematic Qualitative Review\",\"authors\":\"J. Sumankuuro, Frances Griffiths, A. Koon, Witness Mapanga, Beryl Maritim, A. Mosam, J. Goudge\",\"doi\":\"10.34172/ijhpm.2023.7352\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Efforts to move towards universal health coverage (UHC) aim to rebalance health financing in ways that increase efficiency, equity, and quality. Resource constraints require a shift from passive to strategic purchasing (SP). In this paper, we report on the experiences of SP in public sector health insurance schemes in nine middle-income countries to understand what extent SP has been established, the challenges and facilitators, and how it is helping countries achieve their UHC goals. Methods: We conducted a systematic search to identify papers on SP. Nine countries were selected for case study analysis. We extracted data from 129 articles. We used a common framework to compare the purchasing arrangements and key features in the different schemes. The evidence was synthesised qualitatively. Results: Five countries had health technology assessment (HTA) units to research what services to buy. Most schemes had reimbursement mechanisms that enabled some degree of cost control. However, we found evidenced-based changes to the reimbursement mechanisms only in Thailand and China. All countries have some form of mechanism for accreditation of health facilities, although there was considerable variation in what is done. All countries had some strategy for monitoring claims, but they vary in complexity and the extent of implementation; three countries have implemented e-claim processing enabling a greater level of monitoring. Only four countries had independent governance structures to provide oversight. We found delayed reimbursement (six countries), failure to provide services in the benefits package (four countries), and high out-of-pocket (OOP) payments in all countries except Thailand and Indonesia, suggesting the schemes were failing their members. Conclusion: We recommend investment in purchaser and research capacity and a focus on strong governance, including regular engagement between the purchaser, provider and citizens, to build trusting relationships to leverage the potential of SP more fully, and expand financial protection and progress towards UHC.\",\"PeriodicalId\":14135,\"journal\":{\"name\":\"International Journal of Health Policy and Management\",\"volume\":\"39 1\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2023-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Health Policy and Management\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.34172/ijhpm.2023.7352\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Health Policy and Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.34172/ijhpm.2023.7352","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:实现全民医保(UHC)的努力旨在以提高效率、公平性和质量的方式重新平衡医疗筹资。资源的限制要求我们从被动采购向战略采购(SP)转变。在本文中,我们报告了九个中等收入国家公共部门医疗保险计划中战略性采购的经验,以了解战略性采购在多大程度上得以确立、面临的挑战和促进因素,以及战略性采购如何帮助各国实现全民医保目标。方法:我们进行了系统检索,以确定有关 SP 的论文。我们选择了九个国家进行案例研究分析。我们从 129 篇文章中提取了数据。我们使用一个共同框架来比较不同计划的采购安排和主要特点。对证据进行了定性综合。结果五个国家设有卫生技术评估 (HTA) 单位,负责研究购买何种服务。大多数计划都有报销机制,可以在一定程度上控制成本。然而,我们发现只有泰国和中国对报销机制进行了循证改革。所有国家都有某种形式的医疗机构认证机制,尽管在认证内容上存在很大差异。所有国家都制定了某种监督报销的战略,但其复杂程度和实施范围各不相同;有三个国家实施了电子报销处理,从而实现了更大程度的监督。只有四个国家有独立的管理机构进行监督。我们发现,除泰国和印度尼西亚外,所有国家都存在报销延迟(6 个国家)、未能提供一揽子福利服务(4 个国家)以及自付费用(OOP)过高等问题,这表明这些计划辜负了其成员的期望。结论:我们建议对购买者和研究能力进行投资,并注重强有力的管理,包括购买者、提供者和公民之间的定期接触,以建立相互信任的关系,从而更充分地发挥 SP 的潜力,并扩大财务保护和实现全民医保的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Experiences of Strategic Purchasing of Healthcare in Nine Middle-Income Countries: A Systematic Qualitative Review
Background: Efforts to move towards universal health coverage (UHC) aim to rebalance health financing in ways that increase efficiency, equity, and quality. Resource constraints require a shift from passive to strategic purchasing (SP). In this paper, we report on the experiences of SP in public sector health insurance schemes in nine middle-income countries to understand what extent SP has been established, the challenges and facilitators, and how it is helping countries achieve their UHC goals. Methods: We conducted a systematic search to identify papers on SP. Nine countries were selected for case study analysis. We extracted data from 129 articles. We used a common framework to compare the purchasing arrangements and key features in the different schemes. The evidence was synthesised qualitatively. Results: Five countries had health technology assessment (HTA) units to research what services to buy. Most schemes had reimbursement mechanisms that enabled some degree of cost control. However, we found evidenced-based changes to the reimbursement mechanisms only in Thailand and China. All countries have some form of mechanism for accreditation of health facilities, although there was considerable variation in what is done. All countries had some strategy for monitoring claims, but they vary in complexity and the extent of implementation; three countries have implemented e-claim processing enabling a greater level of monitoring. Only four countries had independent governance structures to provide oversight. We found delayed reimbursement (six countries), failure to provide services in the benefits package (four countries), and high out-of-pocket (OOP) payments in all countries except Thailand and Indonesia, suggesting the schemes were failing their members. Conclusion: We recommend investment in purchaser and research capacity and a focus on strong governance, including regular engagement between the purchaser, provider and citizens, to build trusting relationships to leverage the potential of SP more fully, and expand financial protection and progress towards UHC.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Health Policy and Management
International Journal of Health Policy and Management Health Professions-Health Information Management
CiteScore
5.40
自引率
14.30%
发文量
142
审稿时长
9 weeks
期刊介绍: International Journal of Health Policy and Management (IJHPM) is a monthly open access, peer-reviewed journal which serves as an international and interdisciplinary setting for the dissemination of health policy and management research. It brings together individual specialties from different fields, notably health management/policy/economics, epidemiology, social/public policy, and philosophy into a dynamic academic mix.
期刊最新文献
Why Are African Researchers Left Behind in Global Scientific Publications? - A Viewpoint. Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study". Phase IV Drug Trials With a Canadian Site: A Comparison of Industry and Non-Industry-Funded Trials. The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism. Gaza as a Case in Point. Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1